Skip to main content
Top
Published in: Cost Effectiveness and Resource Allocation 1/2023

Open Access 01-12-2023 | Research

Resource allocation in public sector programmes: does the value of a life differ between governmental departments?

Authors: Patricia Cubi-Molla, David Mott, Nadine Henderson, Bernarda Zamora, Mendel Grobler, Martina Garau

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2023

Login to get access

Abstract

Background

The value of a life is regularly monetised by government departments for informing resource allocation. Guidance documents indicate how economic evaluation should be conducted, often specifying precise values for different impacts. However, we find different values of life and health are used in analyses by departments within the same government despite commonality in desired outcomes. This creates potential inconsistencies in considering trade-offs within a broader public sector spending budget. We provide evidence to better inform the political process and to raise important issues in assessing the value of public expenditure across different sectors.

Methods

Our document analysis identifies thresholds, explicitly or implicitly, as observed in government-related publications in the following public sectors: health, social care, transport, and environment. We include both demand-side and supply-side thresholds, understood as societies’ and governments’ willingness to pay for health gains. We look at key countries that introduced formal economic evaluation processes early on and have impacted other countries’ policy development: Australia, Canada, Japan, New Zealand, the Netherlands, and the United Kingdom. We also present a framework to consider how governments allocate resources across different public services.

Results

Our analysis supports that identifying and describing the Value of a Life from disparate public sector activities in a manner that facilitates comparison is theoretically meaningful. The optimal allocation of resources across sectors depends on the relative position of benefits across different attributes, weighted by the social value that society puts on them. The value of a Quality-Adjusted Life Year is generally used as a demand-side threshold by Departments of transport and environment. It exceeds those used in health, often by a large enough proportion to be a multiple thereof. Decisions made across departments are generally based on an unspecified rationing rule.

Conclusions

Comparing government expenditure across different public sector departments, in terms of the value of each department outcome, is not only possible but also desirable. It is essential for an optimal resource allocation to identify the relevant social attributes and to quantify the value of these attributes for each department.
Appendix
Available only for authorised users
Footnotes
1
Excel files showing the sensitivity analysis are available upon request.
 
2
We could not identify an official document recommending the use of this supply-side threshold – beyond its use in impact assessment reports. Note that the £15,000 number is not used by the NHS in reviewing its spending programmes, or by NICE in its HTA appraisals on behalf of the NHS. We include the figure in the results for UK for completeness. However, since impact assessment reports were beyond the scope of our search for other countries, we do not include this threshold in our analysis, as a matter of consistency.
 
3
Note that we have not considered the possibility of taxation changes, i.e., we are simply limiting consideration to the relative allocation of resources and where sub-optimal outcomes are generated within that.
 
Literature
1.
go back to reference Montibeller G, Franco A. Resource allocation in local government with facilitated portfolio decision analysis. Portfolio decision analysis: improved methods for resource allocation. New York: Springer Science & Business Media; 2011. Montibeller G, Franco A. Resource allocation in local government with facilitated portfolio decision analysis. Portfolio decision analysis: improved methods for resource allocation. New York: Springer Science & Business Media; 2011.
2.
go back to reference Barroy H, Gupta S. From Overall Fiscal Space to Budgetary Space for Health: Connecting Public Financial Management to Resource Mobilization in the Era of COVID-19. Center for Global Development (CGD) Policy papers. 2020; CGD Policy Paper 185. Barroy H, Gupta S. From Overall Fiscal Space to Budgetary Space for Health: Connecting Public Financial Management to Resource Mobilization in the Era of COVID-19. Center for Global Development (CGD) Policy papers. 2020; CGD Policy Paper 185.
3.
go back to reference Weinstein M, Zeckhauser R. Critical ratios and efficient allocation. J Public Econ. 1973;2:147–57.CrossRef Weinstein M, Zeckhauser R. Critical ratios and efficient allocation. J Public Econ. 1973;2:147–57.CrossRef
4.
go back to reference Boardman AE. “Plug-in” shadow price estimates for policy analysis. Ann Reg Sci. 1997;31:299–324.CrossRef Boardman AE. “Plug-in” shadow price estimates for policy analysis. Ann Reg Sci. 1997;31:299–324.CrossRef
5.
go back to reference Dolan P, Layard R, Metcalfe R. Measuring subjective wellbeing for public policy: recommendations on measures. 2011;23 Dolan P, Layard R, Metcalfe R. Measuring subjective wellbeing for public policy: recommendations on measures. 2011;23
6.
go back to reference Borge L-E, Falch T, Tovmo P. Public sector efficiency: the roles of political and budgetary institutions, fiscal capacity, and democratic participation. Public Choice. 2008;136:475–95.CrossRef Borge L-E, Falch T, Tovmo P. Public sector efficiency: the roles of political and budgetary institutions, fiscal capacity, and democratic participation. Public Choice. 2008;136:475–95.CrossRef
7.
go back to reference New Zealand Treasury. CBAx Tool User Guidance: Guide for departments and agencies using Treasury’s CBAx tool for cost benefit analysis. Wellington: New Zealand Government: The Treasury; 2018. New Zealand Treasury. CBAx Tool User Guidance: Guide for departments and agencies using Treasury’s CBAx tool for cost benefit analysis. Wellington: New Zealand Government: The Treasury; 2018.
8.
go back to reference Luyten J, Denier Y. Explicit cost-effectiveness thresholds in health care: a kaleidoscope. Soc Justice Res. 2019;32:155–71.CrossRef Luyten J, Denier Y. Explicit cost-effectiveness thresholds in health care: a kaleidoscope. Soc Justice Res. 2019;32:155–71.CrossRef
9.
go back to reference Devlin N, Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ. 2004;13:437–52.CrossRefPubMed Devlin N, Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ. 2004;13:437–52.CrossRefPubMed
10.
go back to reference Ghijben P, Gu Y, Lancsar E, Zavarsek S. Revealed and stated preferences of decision makers for priority setting in health technology assessment: a systematic review. Pharmacoeconomics. 2018;36:323–40.CrossRefPubMed Ghijben P, Gu Y, Lancsar E, Zavarsek S. Revealed and stated preferences of decision makers for priority setting in health technology assessment: a systematic review. Pharmacoeconomics. 2018;36:323–40.CrossRefPubMed
12.
go back to reference Hernandez-Villafuerte K, Zamora B, Towse A. Issues surrounding the estimation of the opportunity cost of adopting a new health care technology: areas for further research. London: Office of Health Economics; 2018. Hernandez-Villafuerte K, Zamora B, Towse A. Issues surrounding the estimation of the opportunity cost of adopting a new health care technology: areas for further research. London: Office of Health Economics; 2018.
13.
go back to reference Culyer AJ. Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use. Health Econ Policy Law. 2016;11:415–32.CrossRefPubMed Culyer AJ. Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use. Health Econ Policy Law. 2016;11:415–32.CrossRefPubMed
14.
go back to reference Martin S, Rice N, Smith PC. Does health care spending improve health outcomes? Evidence from English programme budgeting data. J Health Econ. 2008;27:826–42.CrossRefPubMed Martin S, Rice N, Smith PC. Does health care spending improve health outcomes? Evidence from English programme budgeting data. J Health Econ. 2008;27:826–42.CrossRefPubMed
15.
go back to reference Meltzer DO, Smith PC. Theoretical Issues Relevant to the Economic Evaluation of Health Technologies11We are grateful for comments from participants at the Handbook’s authors’ workshop at Harvard University, and from David Epstein at the University of Granada, and Pedro Pita Barros at the Universidade Nova, Lisbon. Handbook of Health Economics. Elsevier; 2011; p. 433–69. http://linkinghub.elsevier.com/retrieve/pii/B9780444535924000074. Accessed 12 Sep 2018. Meltzer DO, Smith PC. Theoretical Issues Relevant to the Economic Evaluation of Health Technologies11We are grateful for comments from participants at the Handbook’s authors’ workshop at Harvard University, and from David Epstein at the University of Granada, and Pedro Pita Barros at the Universidade Nova, Lisbon. Handbook of Health Economics. Elsevier; 2011; p. 433–69. http://​linkinghub.​elsevier.​com/​retrieve/​pii/​B978044453592400​0074. Accessed 12 Sep 2018.
16.
go back to reference Kind P. Putting the ‘Q’ in QALYs. In: Mason A, Towse A, editors. The Ideas and Influence of Alan Williams BE REASONABLE – DO IT MY WAY! Abingdon: Radcliffe Publishing Ltd; 2008. Kind P. Putting the ‘Q’ in QALYs. In: Mason A, Towse A, editors. The Ideas and Influence of Alan Williams BE REASONABLE – DO IT MY WAY! Abingdon: Radcliffe Publishing Ltd; 2008.
17.
go back to reference NICE. Guide to the methods of technology appraisal. London: NICE; 2013. NICE. Guide to the methods of technology appraisal. London: NICE; 2013.
19.
go back to reference HM Treasury. The Green Book: central government guidance on appraisal and evaluation. 2022. HM Treasury. The Green Book: central government guidance on appraisal and evaluation. 2022.
20.
go back to reference Woods B, Fox A, Sculpher M, Claxton K. Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems. Health Econ. 2021;30:2649–66.CrossRefPubMedPubMedCentral Woods B, Fox A, Sculpher M, Claxton K. Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems. Health Econ. 2021;30:2649–66.CrossRefPubMedPubMedCentral
24.
go back to reference Giles M. The cost of road crashes: a comparison of methods and recent Australian estimates. JTEP. 2003;37:95–110. Giles M. The cost of road crashes: a comparison of methods and recent Australian estimates. JTEP. 2003;37:95–110.
25.
go back to reference Roy R, Braathen NA. The Rising Cost of Ambient Air Pollution thus far in the 21st Century: Results from the BRIICS and the OECD Countries. Paris: OECD; 2017. Report No.: 124. Roy R, Braathen NA. The Rising Cost of Ambient Air Pollution thus far in the 21st Century: Results from the BRIICS and the OECD Countries. Paris: OECD; 2017. Report No.: 124.
26.
go back to reference Vallejo-Torres L, García-Lorenzo B, Castilla I, Valcárcel-Nazco C, García-Pérez L, Linertová R, et al. On the estimation of the cost-effectiveness threshold: why, what, how? Value Health. 2016;19:558–66.CrossRefPubMed Vallejo-Torres L, García-Lorenzo B, Castilla I, Valcárcel-Nazco C, García-Pérez L, Linertová R, et al. On the estimation of the cost-effectiveness threshold: why, what, how? Value Health. 2016;19:558–66.CrossRefPubMed
27.
go back to reference Abelson P. The value of life and health for public policy. Econ Record. 2003;79:S2-13.CrossRef Abelson P. The value of life and health for public policy. Econ Record. 2003;79:S2-13.CrossRef
28.
go back to reference Glover D, Henderson J. Quantifying health impacts of government policies. Department of Health; 2010. Glover D, Henderson J. Quantifying health impacts of government policies. Department of Health; 2010.
29.
go back to reference Vallejo-Torres L, García-Lorenzo B, Serrano-Aguilar P. Estimating a cost-effectiveness threshold for the Spanish NHS. Health Econ. 2018;27:746–61.CrossRefPubMed Vallejo-Torres L, García-Lorenzo B, Serrano-Aguilar P. Estimating a cost-effectiveness threshold for the Spanish NHS. Health Econ. 2018;27:746–61.CrossRefPubMed
30.
go back to reference Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, et al. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess. 2015;19:1–504.CrossRefPubMedPubMedCentral Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, et al. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess. 2015;19:1–504.CrossRefPubMedPubMedCentral
32.
go back to reference Lomas J, Ochalek J, Faria R. Avoiding opportunity cost neglect in cost-effectiveness analysis for health technology assessment. Appl Health Econ Health Policy. 2022;20:13–8.CrossRefPubMed Lomas J, Ochalek J, Faria R. Avoiding opportunity cost neglect in cost-effectiveness analysis for health technology assessment. Appl Health Econ Health Policy. 2022;20:13–8.CrossRefPubMed
33.
go back to reference Hisashige A. History of healthcare technology assessment in Japan. Int J Technol Assess Health Care. 2009;25:210–8.CrossRefPubMed Hisashige A. History of healthcare technology assessment in Japan. Int J Technol Assess Health Care. 2009;25:210–8.CrossRefPubMed
34.
go back to reference Sharma D, Aggarwal AK, Downey LE, Prinja S. National healthcare economic evaluation guidelines: a cross-country comparison. PharmacoEconomics Open. 2021;5:349–64.CrossRefPubMedPubMedCentral Sharma D, Aggarwal AK, Downey LE, Prinja S. National healthcare economic evaluation guidelines: a cross-country comparison. PharmacoEconomics Open. 2021;5:349–64.CrossRefPubMedPubMedCentral
35.
go back to reference Brouwer WBF, Culyer AJ, van Exel NJA, Rutten FFH. Welfarism vs. extra-welfarism. J Health Econ. 2008;27:325–38.CrossRefPubMed Brouwer WBF, Culyer AJ, van Exel NJA, Rutten FFH. Welfarism vs. extra-welfarism. J Health Econ. 2008;27:325–38.CrossRefPubMed
37.
go back to reference Griffin S, Claxton K, Sculpher M. Decision analysis for resource allocation in health care. J Health Serv Res Policy. 2008;13:23–30.CrossRefPubMed Griffin S, Claxton K, Sculpher M. Decision analysis for resource allocation in health care. J Health Serv Res Policy. 2008;13:23–30.CrossRefPubMed
38.
go back to reference Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ. 2006;16:307–17.CrossRef Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ. 2006;16:307–17.CrossRef
39.
go back to reference Chilton S, Jones-Lee M, Metcalf H, Nielsen JS, Baker R, Donaldson C, et al. A scoping study on the valuation of risks to life and health: the monetary Value of a Life year (VOLY). Final report. 2020;75. Chilton S, Jones-Lee M, Metcalf H, Nielsen JS, Baker R, Donaldson C, et al. A scoping study on the valuation of risks to life and health: the monetary Value of a Life year (VOLY). Final report. 2020;75.
40.
go back to reference Mason H, Jones-Lee M, Donaldson C. Modelling the monetary value of a QALY: a new approach based on UK data. Health Econ. 2009;18:933–50.CrossRefPubMed Mason H, Jones-Lee M, Donaldson C. Modelling the monetary value of a QALY: a new approach based on UK data. Health Econ. 2009;18:933–50.CrossRefPubMed
41.
go back to reference Dolan P, Metcalfe R, Munro V, Christensen MC. Valuing lives and life years: anomalies, implications, and an alternative. Health Econ Policy Law. 2008;3:277–300.CrossRefPubMed Dolan P, Metcalfe R, Munro V, Christensen MC. Valuing lives and life years: anomalies, implications, and an alternative. Health Econ Policy Law. 2008;3:277–300.CrossRefPubMed
43.
go back to reference HM Treasury. The Green Book: Central Government Guidance on Appraisal and Evaluation. HM Treasury; 2018. HM Treasury. The Green Book: Central Government Guidance on Appraisal and Evaluation. HM Treasury; 2018.
50.
go back to reference Ten JB. arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ. 2009;10:357–9.CrossRef Ten JB. arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ. 2009;10:357–9.CrossRef
51.
go back to reference CE Delft. Environmental Prices Handbook 2017: Methods and numbers for valuation of environmental impacts. CE Delft; 2017. CE Delft. Environmental Prices Handbook 2017: Methods and numbers for valuation of environmental impacts. CE Delft; 2017.
Metadata
Title
Resource allocation in public sector programmes: does the value of a life differ between governmental departments?
Authors
Patricia Cubi-Molla
David Mott
Nadine Henderson
Bernarda Zamora
Mendel Grobler
Martina Garau
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Cost Effectiveness and Resource Allocation / Issue 1/2023
Electronic ISSN: 1478-7547
DOI
https://doi.org/10.1186/s12962-023-00500-5

Other articles of this Issue 1/2023

Cost Effectiveness and Resource Allocation 1/2023 Go to the issue